| |
Additional References
Freeman J, Panasyuk S, Pease, E, Schomacker,
K. Medical hyperspectral imaging (MHSI) for the assessment
of systemic physiology, Oral Presentation, 16th World Congress
of the World Society of Cardio-Thoracic Surgeons, Ottawa, Canada,
August 18, 2006.
Freeman J, Panasyuk S. Hyperspectral
imaging in medicine. Chance Laboratory Seminar, University of
Pennsylvania, Philadelphia, June 2005.
Afromowitz MA, Callis JB, Heimbach
DM, DeSoto LA, Norton MK. Multispectral imaging of burn
wounds: a new clinical instrument for evaluating burns. IEEE Trans
Biomed Eng 1998; 35 (10): 842-50.
Downs F, Rish J, Freeman J.
Multispectral imagery applications for medical diagnostics. Advanced
Technology Applications to Combat Casualty Care (ATACCC), St.
Petersburg, FL, May, 1997.
Freeman JE, Downs F, Marcucci L, Lewis
EN, Blume B, Rish J., Multispectral and hyperspectral
imaging: applications for medical and surgical diagnostics. Proceedings
of the 19th Annual International Conference of the IEEE Engineering
in Medicine and Biology Society, Chicago, 1997; 701-702.
Dinh T, Panasyuk S, Freeman J, Panasyuk
AA, Lew R, Brand D, Lima C, Giurini JM, Lyons TE, Khaodhiar L,
Veves A. Medical hyperspectral imaging (MHSI) evaluation
of microcirculatory changes to predict clinical outcomes: application
to diabetic foot ulcers. Poster #P-16, Society of Vascular Medicine
and Biology 17th Annual Scientific Session, June 2006 and Vascular
Medicine; Vol 11, Supp 1, S7, June 2006.
Dinh T, Panasyuk S, Jiang C, Freeman
J, Panasyuk AA, Nerney M, Lew R, Brand D, Lima C, Giurini JM,
Lyons TE, Khaodhiar L, Veves A. The use of medical hyperspectral
imaging (MHSI) to evaluate microcirculatory changes in diabetic
foot ulcers and predict clinical outcomes. Abstract presentation
and publication number: 106-OR, Oral session: Diabetic Foot –
More than the Clinical Basics, American Diabetes Association 66th
Scientific Sessions, June 10, 2006 and Diabetes; Vol 55, Supp.1,
A106, June, 2006.
Freeman J, Panasyuk S, Schomacker K.
Medical hyperspectral imaging: (MHSI) – wound healing, diabetic
foot ulcers and progression of systemic disease. Grand Rounds,
Endocrinology, Cleveland Clinic Foundation, February 2006
Dinh T, Panasyuk SV, Tracey BH, Khaodhiar
L, Lyons TE, Rosenblum BI, Giurini JM, Freeman JE, Veves A.
The use of medical hyperspectral imaging (MHSI) to identify patients
at risk for developing diabetic foot ulcers. Poster #1106-P, American
Diabetes Association 65th Annual Sessions, June, 2005 and Diabetes,
Vol 54, Supp. 1, A270, June 2005.
Greenman RI, Panasyuk S, Wang X, Lyons
TE, Dinh T, Longorio L, Giurini JM, Freeman J, Khaodhiar L, Veves
A. Early changes in the skin microcirculation and muscle
metabolism of the diabetic foot. Lancet 2005; 366(12): 1711-1718.
Kellicut D, Mansfield JR, Lew RA, Lewis
EN, Freeman JE, Sidawy A. Hyperspectral imaging of diabetic
foot conditions and peripheral arterial disease, Oral presentation,
18th Annual Meeting of the Eastern Vascular Society, May 2004.
Zuzak K, Schaberle MD, Levin IW, Lewis
EN, Freeman JE, McNeil JD, Cancio LC. Visible and infrared
hyperspectral visualization in normal and ischemic tissue. Proceedings
21st Annual International Conference of the IEEE and Engineering
in Medicine and Biology Society, 1999; 181.
Khaodiar, L, Dinh T, Panasyuk S, Schomacker
K, Freeman J, Panasyuk AA, Lew R, Lima C, Giurini JM, Lyons TE,
Veves A. The use of medical hyperspectral technology
(MHT) to evaluate microcirculatory changes in diabetic foot ulcers
and predict clinical outcomes. Submitted to Diabetes Care.
Macsata R, Freeman J, Panasyuk SV,
Schomacker KT, Lew RA, Sidawy A. The use of hyperspectral
technology in acute limb ischemia. In preparation for submission
to The Journal of Vascular Surgery.
Cancio LC, Batchinski AI, Mansfield
JR, Panasyuk S, Hetz K, Martini DK, Jordan BS, Lew RA, Tracey
B, Freeman JE. Hyperspectral imaging: a new approach
to the diagnosis of hemorrhagic shock. Journal of Trauma, Vol
60, Supp. 5, May, 2006, 1087-1095.
Freeman JE, Panasyuk SV, Holcomb JB,
Cancio LC, Hopmeier MJ, Cooke WI, Convertino VA. Use
of near-infrared medical hyperspectral imaging (MHSI) in the evaluation
of hemodynamic compromise in human subjects. Poster # 30, Eastern
Association for the Surgery of Trauma, Jan, 2006.
Freeman JE, Panasyuk SV, Lew RA, Holcomb
JB, Hopmeier MJ, Cooke WI, Convertino VA. Diagnosis and
evaluation of human hemodynamic compromise using medical hyperspectral
imaging (MHSI) as a stand-off non-invasive method. Poster # 9411,
American Heart Association, Dallas, Nov 2005.
Panasyuk SV, Freeman JE, Lew RA, Tracey
B, Jordon B, Batchinsky AI, Hopmeier MJ, Cancio LC. Use
of a hyperspectral shock index for the early diagnosis of hemorrhagic
shock. Poster # 11090, American Heart Association, Dallas, Nov
2005.
Freeman, JE, Panasyuk SV, Hopmeier
MJ, Lew RA, Batchinski AI, Cancio LC. The evaluation
of new methods of hyperspectral image analysis for the diagnosis
of hemorrhagic shock. Poster #18, American Association for the
Surgery of Trauma, Atlanta, Sept 2005.
Panasyuk SV, Freeman JE, Cooke WI,
Hopmeier MJ, Convertino VA. Initial demonstration in
human subjects of medical hyperspectral imaging (MHSI) as a novel
standoff non-invasive method for diagnosing and measuring hemodynamic
compromise. Poster #17, American Association for the Surgery of
Trauma, Atlanta, Sept 2005.
Freeman JE, Panasyuk SV, Lew RA, Hopmeier
MJ, Holcomb J, Cooke W, Convertino V. The development
of hyperspectral imaging as a stand-off tool for the evaluation
of shock: human studies of lower body negative pressure induced
hemodynamic compromise. Advanced Technology Applications to Combat
Casualty Care (ATACCC), St. Petersburg, FL, Aug 2005.
Cancio LC, Mansfield JR, Batchinski
AI, Jordan BS, Martini DK, Panasyuk SV, Lew RA, Freeman JE.
Hyperspectral imaging: a non-invasive, non-contact approach to
the diagnosis of hemorrhagic shock. Poster #P2, Eastern Association
for the Surgery of Trauma, Dec, 2004 and Journal of Trauma, Vol
57, Issue 6, p.1383, Dec 2004.
Freeman J, Levin R. Commercial
prospects for medical surveillance technology. American Med Informatics
Association Annual Symposium, Washington DC, Nov 2003.
Gillies RJ, Levin RK, Mansfield JR,
Hopmeier MJ, Freeman JE. Use of hyperspectral imaging
to profile cutaneous responses to bioweapons: a concept paper.
Proc. SPIE: Technologies, Systems, and Architectures for Transnational
Defense II; Vol. 5072, p. 32-44, Aug 2003, Mark K. Hamilton, Vince
C. Boles; Eds.
Gillies R, Freeman JE, Cancio LC, Brand
D, Hopmeier MJ, Mansfield JR. Systemic effects of shock
& resuscitation monitored by visible hyperspectral imaging.
Diabetes Technology. & Therapeutics, Volume 5, Number 5, 2003,
847-855.
Cancio LC, Batchinsky A, Lewis EN,
Freeman JE, Lew RA, Mansfield JR. Non-invasive determination
of hypovolemic shock using hyperspectral imaging; Federation of
Applied Chemistry & Spectroscopy Societies (FACSS) Annual
Meeting, Ft. Lauderdale, FL, 2003.
Cancio LC, Mansfield JR, Brand D, Kerby
J, Freeman J, Hopmeier M. Visible hyperspectral imaging:
monitoring the systemic effects of shock and resuscitation. Proc
SPIE Int Soc Opt Eng, 2002; 4614-27.
Freeman JE, Yang S, Panasyuk SV, Lew
RA, Ngo D, Faller DV, Rogers AE. In situ evaluation of
residual breast tumor and tumor grade using medical hyperspectral
imaging (MHSI). Journal of Clinical Oncology, Vol 24, No. 18S,
Part 1; 582s; June, 2006.
Freeman JE, Panasyuk SV, Shi Y, Rogers
AE. The use of medical hyperspectral imaging (MHSI) to
identify residual breast tumor in the surgical resection bed.
Poster #P64-24, Fourth Annual Era of Hope Meeting, Philadelphia,
June 2005 and Era of Hope: Department of Defense Breast Cancer
Research Program Meeting Proceedings; 453, June 2005.
Panasyuk SV, Freeman JE, Shi Y, Rogers
AE. Advantages of intraoperative medical hyperspectral
imaging (MHSI) for the evaluation of the breast cancer resection
bed for residual tumor. Journal of Clinical Oncology, Vol 23,
No. 16S, Part 1; 55s; June 2005.
Freeman JE, Panasyuk SV, Shi Y, Rogers
AE. The use of medical hyperspectral imaging (MHSI) to
identify residual breast tumor in the surgical resection bed.
Era of Hope: Department of Defense Breast Cancer Research Program
Meeting Proceedings, 2005, 453.
Freeman JE, Panasyuk SV, Shi Y, Rogers
AE. The use of medical hyperspectral imaging (MHSI) to
identify residual breast tumor in the surgical resection bed.
Poster #P64-24, Fourth Annual Era of Hope Meeting, Philadelphia,
2005.
Freeman JE, Shi Y, Panasyuk SV, Rogers
AE. Medical hyperspectral imaging (MHSI) of 1, 2-dimethylbenz(a)anthracene
(DMBA)-Induced Breast Tumors in Rats. Poster #1001, 27th Annual
San Antonio Breast Cancer Symposium, San Antonio, Texas, Dec,
2004 and Breast Cancer Research and Treatment, Vol 88, Supp 1,
S51, Dec 2004.
Freeman JE, Yang S, Panasyuk SV, Faller,
DV, Ngo D, Rogers AE. Medical hyperspectral imaging to
facilitate residual tumor identification during resective surgery.
Submitted for publication.
|
|
|
